umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
The investigation of PD-L1 expression as a prognostic marker for uterine sarcoma
Show others and affiliations
2018 (Ukrainian)In: Морфологія, ISSN 1997-9665, Vol. 12, no 2, p. 62-71Article in journal (Refereed) Published
Abstract [en]

Background: The uterine sarcoma is a rare tumor with the unpredictable, aggressive clinical behavior. Medical science relies on the development of reliable tumor markers, on the basis of which the optimal treatment program can be chosen, and will be also possible to make a prognosis. The hyperexpression of PD-L1 in many cases correlates with unfavorable prognosis of the disease and is an important prognostic biomarker for some types of tumors: melanoma, kidney cancer, non-small cell lung cancer. The role of PD-L1 expression, as a tumor marker in sarcoma, remains unclear. Objective. The investigation of PD-L1 expression as a prognostic tumor marker for uterine sarcoma.

Methods: There have been selected 30 uterine sarcoma patients stage I-II (T1-2NxM0), for immunohistochemistry analyze of PD-L1 expression. Depending on the morphological tumor types all the patients were distributed: leiomyosarcoma (LMS) - 20.0%, endometrial stromal sarcoma (ESS) - 46.7%, undifferentiated sarcoma (HC) - 33.3%.

Results: Our results showed that 73.3 % of patients with uterine sarcoma exhibited low expression level of PD-L1. The moderate level and overexpression of PD-L1 were observed in undifferentiated and endometrial stromal sarcoma - 13.3 and 6.7 %, respectively. At further follow-up of patients with PD-L1 expression, the relapse of the disease was detected in 50.0 % of cases.

Conclusion: The PD-L1 expression in tumor tissue, regardless of its level, is considered to be an unfavorable prognostic factor for uterine sarcoma patients. In case of moderate expression level of PD-L1, so as at its overexpression, the tumor progression was detected in 83.3% of uterine sarcoma patients.

Place, publisher, year, edition, pages
2018. Vol. 12, no 2, p. 62-71
Keywords [en]
uterine sarcoma, tumor-marker expression, PD-L1, prognostic factor
National Category
Cancer and Oncology
Research subject
Oncology
Identifiers
URN: urn:nbn:se:umu:diva-153258DOI: 10.26641/1997-9665.2018.2.62-71OAI: oai:DiVA.org:umu-153258DiVA, id: diva2:1262824
Available from: 2018-11-13 Created: 2018-11-13 Last updated: 2018-11-13Bibliographically approved

Open Access in DiVA

fulltext(613 kB)68 downloads
File information
File name FULLTEXT02.pdfFile size 613 kBChecksum SHA-512
487c3c23cdd4c16765c781aad478e6107241324bf5cbbc2bc143157491cf5f8d1952f8892907f3f2666615cb20bb020482e8c80288c248fa0c6bf535de89207f
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Authority records BETA

Lindquist, David

Search in DiVA

By author/editor
Lindquist, David
By organisation
Oncology
In the same journal
Морфологія
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 68 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 505 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf